These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 15721468)

  • 1. HIV-infected women in ART programmes.
    Myer L; Morroni C; Nachega J; Cooper D
    Lancet; 2005 Feb 19-25; 365(9460):655-6. PubMed ID: 15721468
    [No Abstract]   [Full Text] [Related]  

  • 2. The imperative for family planning in ART therapy in Africa.
    Shelton JD; Peterson EA
    Lancet; 2004 Nov 27-Dec 3; 364(9449):1916-8. PubMed ID: 15566991
    [No Abstract]   [Full Text] [Related]  

  • 3. The real challenges for scaling up ART in sub-Saharan Africa.
    Van Damme W; Kober K; Laga M
    AIDS; 2006 Mar; 20(5):653-6. PubMed ID: 16514294
    [No Abstract]   [Full Text] [Related]  

  • 4. ART in low-resource settings: how to do more with less.
    Koole O; Colebunders R
    Lancet; 2010 Aug; 376(9739):396-8. PubMed ID: 20638119
    [No Abstract]   [Full Text] [Related]  

  • 5. Initiation of antiretroviral therapy among pregnant women in resource-limited countries: CD4+ cell count response and program retention.
    Toro PL; Katyal M; Carter RJ; Myer L; El-Sadr WM; Nash D; Abrams EJ;
    AIDS; 2010 Feb; 24(4):515-24. PubMed ID: 19996939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiretroviral therapy in low-resource settings.
    Cainelli F; Lanzafame M; Vento S
    Lancet; 2010 Oct; 376(9750):1392. PubMed ID: 20971363
    [No Abstract]   [Full Text] [Related]  

  • 7. Reconsidering the impact of conflict on HIV infection among women in the era of antiretroviral treatment scale-up in sub-Saharan Africa: a gender lens.
    Shannon K; Kaida A; Rachlis B; Lloyd-Smith E; Gray G; Strathdee SA
    AIDS; 2008 Sep; 22(14):1705-7. PubMed ID: 18753938
    [No Abstract]   [Full Text] [Related]  

  • 8. Predicting the failure of 3 by 5.
    Brown RC; Brown JE
    Lancet; 2005 Jul 9-15; 366(9480):117-8. PubMed ID: 16005323
    [No Abstract]   [Full Text] [Related]  

  • 9. Predicting the failure of 3 by 5.
    Harries AD
    Lancet; 2005 Jul 9-15; 366(9480):117. PubMed ID: 16005322
    [No Abstract]   [Full Text] [Related]  

  • 10. Patterns of HIV-1 drug resistance after first-line antiretroviral therapy (ART) failure in 6 sub-Saharan African countries: implications for second-line ART strategies.
    Hamers RL; Sigaloff KC; Wensing AM; Wallis CL; Kityo C; Siwale M; Mandaliya K; Ive P; Botes ME; Wellington M; Osibogun A; Stevens WS; Rinke de Wit TF; Schuurman R;
    Clin Infect Dis; 2012 Jun; 54(11):1660-9. PubMed ID: 22474222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical presentations of severe cutaneous drug reactions in HIV-infected Africans.
    Lehloenya RJ; Kgokolo M
    Dermatol Clin; 2014 Apr; 32(2):227-35. PubMed ID: 24680008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sexual and reproductive health in HIV serodiscordant couples.
    Makwe CC; Giwa-Osagie OF
    Afr J Reprod Health; 2013 Dec; 17(4 Spec No):99-106. PubMed ID: 24689321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cohort profile: the paediatric antiretroviral treatment programmes in lower-income countries (KIDS-ART-LINC) collaboration.
    Arrivé E; Kyabayinze DJ; Marquis B; Tumwesigye N; Kieffer MP; Azondekon A; Wemin L; Fassinou P; Newell ML; Leroy V; Abrams EJ; Cotton M; Boulle A; Mbori-Ngacha D; Dabis F;
    Int J Epidemiol; 2008 Jun; 37(3):474-80. PubMed ID: 17998240
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment. Individual approach needed for co-infections.
    AIDS Policy Law; 2011 Dec; 27(1):1. PubMed ID: 22319816
    [No Abstract]   [Full Text] [Related]  

  • 15. Directly observed therapy for HIV/tuberculosis co-infection.
    Lurie MN; Carter EJ; Cohen J; Flanigan TP
    Lancet Infect Dis; 2004 Mar; 4(3):137-8. PubMed ID: 14998498
    [No Abstract]   [Full Text] [Related]  

  • 16. Finding patients eligible for antiretroviral therapy using TB services as entry point for HIV treatment.
    Bwire R; Nagelkerke NJ; Borgdorff MW
    Trop Med Int Health; 2006 Oct; 11(10):1567-75. PubMed ID: 17002731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting the failure of 3 by 5.
    Lancet; 2005 May 7-13; 365(9471):1597. PubMed ID: 15889458
    [No Abstract]   [Full Text] [Related]  

  • 18. Providing HIV care for co-infected tuberculosis patients: a perspective from sub-Saharan Africa.
    Harries AD; Zachariah R; Lawn SD
    Int J Tuberc Lung Dis; 2009 Jan; 13(1):6-16. PubMed ID: 19105873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Avoiding HIV and dying of syphilis.
    Peeling RW; Mabey D; Fitzgerald DW; Watson-Jones D
    Lancet; 2004 Oct 30-Nov 5; 364(9445):1561-3. PubMed ID: 15519615
    [No Abstract]   [Full Text] [Related]  

  • 20. Trial finds simultaneous HIV/tuberculosis treatment beneficial.
    Baleta A
    Lancet Infect Dis; 2008 Nov; 8(11):669. PubMed ID: 18992400
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.